Werner Kroll
Chief Tech/Sci/R&D Officer en QUIDELORTHO CORPORATION .
Fortuna: 2 M $ al 31/03/2024
Perfil
Werner Kroll es Vicepresidente Senior de Investigación y Desarrollo de Quidel Corp. El Dr. Kroll también forma parte del consejo de la Asociación Europea de Medicina Personalizada. Anteriormente, el Dr. Kroll fue vicepresidente y director de investigación e innovación en Novartis Institutes for Biomedical Research, Inc. El Dr. Kroll se doctoró en la Universidad Philipps de Marburgo.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
QUIDELORTHO CORPORATION
0.05% | 28/03/2024 | 35 781 ( 0.05% ) | 2 M $ | 31/03/2024 |
Cargos activos de Werner Kroll
| Empresas | Cargo | Inicio |
|---|---|---|
| QUIDELORTHO CORPORATION | Chief Tech/Sci/R&D Officer | - |
| European Personalised Medicine Association | Director/Board Member | - |
Antiguos cargos conocidos de Werner Kroll.
| Empresas | Cargo | Fin |
|---|---|---|
Quidel Corp.
 Quidel Corp. Medical SpecialtiesHealth Technology Quidel Corp. engages in the development, manufacture and market of rapid diagnostic testing solutions. Its portfolio includes rapid immunoassays, cardiac immunoassays, specialized diagnostic solutions and molecular diagnostic solutions. The firm products are directly sold to end users and distributors and for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies and wellness screening centers. The company was founded in 1979 and is headquartered in San Diego, CA. | Chief Tech/Sci/R&D Officer | 01/01/2022 |
Novartis Institutes for Biomedical Research, Inc.
 Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Formación de Werner Kroll.
| Philipps University of Marburg | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| QUIDELORTHO CORPORATION | Health Technology |
| Empresas privadas | 3 |
|---|---|
Quidel Corp.
Quidel Corp. Medical SpecialtiesHealth Technology Quidel Corp. engages in the development, manufacture and market of rapid diagnostic testing solutions. Its portfolio includes rapid immunoassays, cardiac immunoassays, specialized diagnostic solutions and molecular diagnostic solutions. The firm products are directly sold to end users and distributors and for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies and wellness screening centers. The company was founded in 1979 and is headquartered in San Diego, CA. | Health Technology |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Commercial Services |
| European Personalised Medicine Association |
- Bolsa de valores
- Insiders
- Werner Kroll
